George Hampton
Director/Board Member chez AMRYT PHARMA PLC
Profil
George P.
Hampton currently works at Currax Pharmaceuticals LLC, as Chief Executive Officer & Director from 2019 and Amryt Pharma Plc, as Non-Executive Director from 2019.
Mr. Hampton also formerly worked at Global Village Concerns, as President & Chief Executive Officer from 2009 to 2015, Amryt Pharma Holdings Ltd., as Non-Executive Director, IMAC Holdings, Inc., as Independent Director from 2019 to 2020, Horizon Therapeutics Plc, as EVP-Global Orphan Business Unit from 2015 to 2016, and Horizon Pharmaceuticals, Inc., as Executive Vice President-Primary Care Business from 2016 to 2018.
Mr. Hampton received his undergraduate degree from Miami University.
Postes actifs de George Hampton
| Sociétés | Poste | Début |
|---|---|---|
| AMRYT PHARMA PLC | Director/Board Member | 24/09/2019 |
Currax Pharmaceuticals LLC
 Currax Pharmaceuticals LLC Drugstore ChainsRetail Trade Currax Pharmaceuticals LLC engages in operation of a pharmaceutical business focused on acquiring and commercializing prescription drugs. It offers branded and generic products. The company is headquartered in Brentwood, TN. | Chief Executive Officer | 01/04/2019 |
Anciens postes connus de George Hampton
| Sociétés | Poste | Fin |
|---|---|---|
| IMAC HOLDINGS, INC. | Director/Board Member | 21/10/2020 |
Horizon Pharmaceuticals, Inc.
 Horizon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Horizon Pharmaceuticals, Inc. is a pharmaceutical company that specializes in the development, manufacture, and lifecycle management of blow-fill-seal (BFS) technology and products for the pharmaceutical, medical device, diagnostic, and clinical industries. The private company is based in West Palm Beach, FL and operates two segments: blow-fill-seal drug discovery and development and blow-fill-seal manufacturing, including in-house mold fabrication. The company is a leader in custom BFS aseptic manufacturing and have the capabilities to complete projects at any stage of the development cycle. The company also holds a state license for the manufacture of pharmaceutical drugs (OTC and prescription) and medical devices. | Corporate Officer/Principal | 01/10/2018 |
Global Village Concerns
 Global Village Concerns Miscellaneous Commercial ServicesCommercial Services Global Village Concerns provides online social commerce services. The private company is based in San Diego. | Chief Executive Officer | 01/02/2015 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Formation de George Hampton
| Miami University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMAC HOLDINGS, INC. | Health Services |
| Entreprise privées | 6 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Horizon Pharmaceuticals, Inc.
Horizon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Horizon Pharmaceuticals, Inc. is a pharmaceutical company that specializes in the development, manufacture, and lifecycle management of blow-fill-seal (BFS) technology and products for the pharmaceutical, medical device, diagnostic, and clinical industries. The private company is based in West Palm Beach, FL and operates two segments: blow-fill-seal drug discovery and development and blow-fill-seal manufacturing, including in-house mold fabrication. The company is a leader in custom BFS aseptic manufacturing and have the capabilities to complete projects at any stage of the development cycle. The company also holds a state license for the manufacture of pharmaceutical drugs (OTC and prescription) and medical devices. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Global Village Concerns
Global Village Concerns Miscellaneous Commercial ServicesCommercial Services Global Village Concerns provides online social commerce services. The private company is based in San Diego. | Commercial Services |
Currax Pharmaceuticals LLC
Currax Pharmaceuticals LLC Drugstore ChainsRetail Trade Currax Pharmaceuticals LLC engages in operation of a pharmaceutical business focused on acquiring and commercializing prescription drugs. It offers branded and generic products. The company is headquartered in Brentwood, TN. | Retail Trade |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
